JPWO2019191418A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019191418A5 JPWO2019191418A5 JP2021502719A JP2021502719A JPWO2019191418A5 JP WO2019191418 A5 JPWO2019191418 A5 JP WO2019191418A5 JP 2021502719 A JP2021502719 A JP 2021502719A JP 2021502719 A JP2021502719 A JP 2021502719A JP WO2019191418 A5 JPWO2019191418 A5 JP WO2019191418A5
- Authority
- JP
- Japan
- Prior art keywords
- aav6
- modified
- raav6
- vector
- neutralization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013598 vector Substances 0.000 claims description 139
- 241000972680 Adeno-associated virus - 6 Species 0.000 claims description 122
- 238000006386 neutralization reaction Methods 0.000 claims description 63
- 150000001413 amino acids Chemical class 0.000 claims description 60
- 210000004185 liver Anatomy 0.000 claims description 40
- 238000006467 substitution reaction Methods 0.000 claims description 32
- 238000010361 transduction Methods 0.000 claims description 30
- 230000026683 transduction Effects 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 27
- 241000700605 Viruses Species 0.000 claims description 20
- 238000012216 screening Methods 0.000 claims description 18
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims description 14
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 13
- 210000002845 virion Anatomy 0.000 claims description 12
- 210000005229 liver cell Anatomy 0.000 claims description 7
- 125000000539 amino acid group Chemical group 0.000 claims description 6
- 230000002440 hepatic effect Effects 0.000 claims description 6
- 210000003494 hepatocyte Anatomy 0.000 claims description 6
- 238000002703 mutagenesis Methods 0.000 claims description 6
- 231100000350 mutagenesis Toxicity 0.000 claims description 6
- 238000002804 saturated mutagenesis Methods 0.000 claims description 6
- 230000010415 tropism Effects 0.000 claims description 6
- 230000009467 reduction Effects 0.000 claims description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 4
- 241000282560 Macaca mulatta Species 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 description 11
- 210000000234 capsid Anatomy 0.000 description 9
- 241000702421 Dependoparvovirus Species 0.000 description 7
- 241001655883 Adeno-associated virus - 1 Species 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 108091033409 CRISPR Proteins 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 239000013607 AAV vector Substances 0.000 description 3
- 238000010446 CRISPR interference Methods 0.000 description 3
- 108060001084 Luciferase Proteins 0.000 description 3
- 239000005089 Luciferase Substances 0.000 description 3
- 108091027967 Small hairpin RNA Proteins 0.000 description 3
- 108700019146 Transgenes Proteins 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000004055 small Interfering RNA Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 2
- 241000702423 Adeno-associated virus - 2 Species 0.000 description 2
- 241001164825 Adeno-associated virus - 8 Species 0.000 description 2
- 238000010354 CRISPR gene editing Methods 0.000 description 2
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 2
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 2
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000005782 double-strand break Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000004602 germ cell Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102100033936 AP-3 complex subunit beta-1 Human genes 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 102100036166 C-X-C chemokine receptor type 1 Human genes 0.000 description 1
- 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 102100028902 Hermansky-Pudlak syndrome 1 protein Human genes 0.000 description 1
- 102100028716 Hermansky-Pudlak syndrome 3 protein Human genes 0.000 description 1
- 102100028715 Hermansky-Pudlak syndrome 4 protein Human genes 0.000 description 1
- 101000779239 Homo sapiens AP-3 complex subunit beta-1 Proteins 0.000 description 1
- 101000947174 Homo sapiens C-X-C chemokine receptor type 1 Proteins 0.000 description 1
- 101000838926 Homo sapiens Hermansky-Pudlak syndrome 1 protein Proteins 0.000 description 1
- 101000985492 Homo sapiens Hermansky-Pudlak syndrome 3 protein Proteins 0.000 description 1
- 101000985501 Homo sapiens Hermansky-Pudlak syndrome 4 protein Proteins 0.000 description 1
- 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 description 1
- 101000764535 Homo sapiens Lymphotoxin-alpha Proteins 0.000 description 1
- 101000864780 Homo sapiens Pulmonary surfactant-associated protein A1 Proteins 0.000 description 1
- 101000651017 Homo sapiens Pulmonary surfactant-associated protein A2 Proteins 0.000 description 1
- 101000612671 Homo sapiens Pulmonary surfactant-associated protein C Proteins 0.000 description 1
- 102100039065 Interleukin-1 beta Human genes 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108010018951 Interleukin-8B Receptors Proteins 0.000 description 1
- 101001089108 Lotus tetragonolobus Anti-H(O) lectin Proteins 0.000 description 1
- 102100026238 Lymphotoxin-alpha Human genes 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102100030060 Pulmonary surfactant-associated protein A1 Human genes 0.000 description 1
- 102100027773 Pulmonary surfactant-associated protein A2 Human genes 0.000 description 1
- 102100040971 Pulmonary surfactant-associated protein C Human genes 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 108091027544 Subgenomic mRNA Proteins 0.000 description 1
- 238000010459 TALEN Methods 0.000 description 1
- 108700012920 TNF Proteins 0.000 description 1
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000002924 silencing RNA Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862649691P | 2018-03-29 | 2018-03-29 | |
| US62/649,691 | 2018-03-29 | ||
| PCT/US2019/024567 WO2019191418A1 (en) | 2018-03-29 | 2019-03-28 | Liver tropic recombinant aav6 vectors that evade neutralization |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021519612A JP2021519612A (ja) | 2021-08-12 |
| JPWO2019191418A5 true JPWO2019191418A5 (https=) | 2022-01-26 |
| JP2021519612A5 JP2021519612A5 (https=) | 2022-01-26 |
Family
ID=68060427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021502719A Pending JP2021519612A (ja) | 2018-03-29 | 2019-03-28 | 中和を回避する肝臓向性組換えａａｖ６ベクター |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210032660A1 (https=) |
| EP (1) | EP3781187A4 (https=) |
| JP (1) | JP2021519612A (https=) |
| CN (1) | CN112218880A (https=) |
| CA (1) | CA3095127A1 (https=) |
| WO (1) | WO2019191418A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210017542A1 (en) * | 2018-03-29 | 2021-01-21 | University Of Florida Research Foundation, Incorporated | Aav6 variants |
| CN117801116A (zh) * | 2022-09-30 | 2024-04-02 | 上海玮美基因科技有限责任公司 | 一种融合型新型腺相关病毒及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006110689A2 (en) * | 2005-04-07 | 2006-10-19 | The Trustees Of The University Of Pennsylvania | Method of increasing the function of an aav vector |
| US9533189B2 (en) * | 2012-05-30 | 2017-01-03 | Jaime Cameron | Push-up exercise apparatus |
| KR102234672B1 (ko) * | 2013-05-21 | 2021-04-06 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도 |
| GB201403684D0 (en) * | 2014-03-03 | 2014-04-16 | King S College London | Vector |
| JP2017048681A (ja) * | 2015-08-31 | 2017-03-09 | 株式会社マーレ フィルターシステムズ | ポンプ |
| BR112018003665A2 (en) * | 2015-09-28 | 2018-09-25 | The University Of North Carolina At Chapel Hill | methods and compositions for antibody evasion viral vectors |
| EP4659816A3 (en) * | 2015-12-14 | 2025-12-31 | The University of North Carolina at Chapel Hill | MODIFIED CAPSID PROTEINS FOR IMPROVED PARVOVIRUS VECTOR DELIVERY |
-
2019
- 2019-03-28 US US17/042,543 patent/US20210032660A1/en not_active Abandoned
- 2019-03-28 EP EP19776047.3A patent/EP3781187A4/en not_active Withdrawn
- 2019-03-28 CA CA3095127A patent/CA3095127A1/en active Pending
- 2019-03-28 WO PCT/US2019/024567 patent/WO2019191418A1/en not_active Ceased
- 2019-03-28 JP JP2021502719A patent/JP2021519612A/ja active Pending
- 2019-03-28 CN CN201980035877.5A patent/CN112218880A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7381706B2 (ja) | 祖先ウイルス配列を予測する方法およびその使用 | |
| US12534717B2 (en) | AAV capsid proteins for nucleic acid transfer | |
| Sonntag et al. | The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes | |
| Yang et al. | A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection | |
| US20210077552A1 (en) | Mutant adeno-associated virus virions and methods of use thereof | |
| JP6947739B2 (ja) | 既存のヒト中和抗体に対して耐性である新規組換えアデノ随伴ウイルスカプシド | |
| JP2021175397A (ja) | 祖先ウイルス配列およびその使用 | |
| Lisowski et al. | Selection and evaluation of clinically relevant AAV variants in a xenograft liver model | |
| Varadi et al. | Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors | |
| KR20210144836A (ko) | 돌연변이된 아데노-연관 바이러스 캡시드 단백질, 이를 포함하는 aav 입자 및 간 특이적 aav 벡터 유전자 치료요법 | |
| Wen et al. | A novel porcine circovirus-like agent P1 is associated with wasting syndromes in pigs | |
| Bello et al. | Novel adeno-associated viruses derived from pig tissues transduce most major organs in mice | |
| Gillet et al. | Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning | |
| US20210292370A1 (en) | Human anti-aav2 capsid polyclonal antibody epitopes | |
| Qian et al. | Directed evolution of AAV serotype 5 for increased hepatocyte transduction and retained low humoral seroreactivity | |
| Kariatsumari et al. | Construction and nucleotide sequence analysis of an infectious DNA clone of the autonomous parvovirus, mink enteritis virus | |
| Sasaki et al. | In search of adeno-associated virus vectors with enhanced cardiac tropism for gene therapy | |
| Bruemmer et al. | Structure of an insect parvovirus (Junonia coenia Densovirus) determined by cryo-electron microscopy | |
| JP2021528639A (ja) | Ａａｖ治療の方法 | |
| JP2021519612A5 (https=) | ||
| US20220332798A1 (en) | Production of anti-viral monoclonal antibodies by hydrodynamic-based transfection | |
| JPWO2019191418A5 (https=) | ||
| Park et al. | Construction of an infectious cDNA clone of genotype 1 avian hepatitis E virus: characterization of its pathogenicity in broiler breeders and demonstration of its utility in studying the role of the hypervariable region in virus replication | |
| CN120435495A (zh) | 抗多种血清型aav衣壳蛋白的单克隆抗体及其制备方法和用途 | |
| CN118324853B (zh) | 腺相关病毒突变体及其应用 |